Inhibition effects of using sequential microtubule depolymerization drug and polymerization drug on tumor cells

By Jia Yuming  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 12, 2008-12 ,pp. : 719-722

Springer Publishing Company

Access to resources Recommend Favorite

Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells

By              

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 297-304

Spandidos Publications

Access to resources Recommend Favorite

The microtubule depolymerizing agent CYT997 effectively kills acute myeloid leukemia cells via activation of caspases and inhibition of PI3K/Akt/mTOR pathway proteins

By            

Experimental and Therapeutic Medicine, Vol. 6, Iss. 2, 2013-01 ,pp. : 299-304

Spandidos Publications

Access to resources Recommend Favorite

Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 2, 2011-02 ,pp. : 202-212

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition

By Welsh S.J.   Hobbs S.   Aherne G.W.  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 378-387

Elsevier

Access to resources Recommend Favorite